Federal Contractor Profile
Emergent Product Development Gaithersburg INC.
Federal contracting record: $2.5B obligated across 16 awards from 2 agencies, FY 2016–2026.
$2.5B
Total Obligated
16
Award Records
2
Agencies Served
6
NAICS Codes
Company Profile
Parent UEI (Unique Entity Identifier)
CNPVCR8DK7M8
Address
300 PROFESSIONAL DR # 100, GAITHERSBURG, MD, 208793419
First Federal Award
Oct 30, 2015
Most Recent Award
Aug 18, 2026
Federal Sales Analytics
Toggle between trend, agency drilldown, and treemap. Use the period selector to focus the time window.
Hover any bar for YoY change + award count. Current fiscal year shown at reduced opacity (partial year).
Top Federal Agencies
- Department of Health and Human Services$2.5B
99.4% of total obligations
- Department of Defense$15M
0.6% of total obligations
Top NAICS Activity
Recent Federal Awards
| Date | Agency | NAICS | Description | Amount |
|---|---|---|---|---|
| Aug 18, 2026 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | IGF::OT::IGF | $24M → |
| Jun 26, 2026 | Department of Health and Human ServicesASPR/ORM-SNS | 325414 | ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM) | $53M → |
| Apr 28, 2026 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAO | 541714 | HIV BIOLOGICS MASTER FILE SUPPORT POP: 4/27/26 TO 3/31/27, EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG, INC. | $11K → |
| Sep 5, 2025 | Department of Health and Human ServicesASPR/ORM-SNS | 325414 | ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM) | $56M → |
| Aug 29, 2025 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | IGF::OT::IGF | $30M → |
| Jan 10, 2025 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541714 | MEDICAL COUNTERMEASURES (MCM) THAT CAN BE DEPLOYED IN THE EVENT OF A FILOVIRUS OUTBREAK ARE A CRUCIAL COMPONENT TO THE UNITED STATES GOVERNMENT?S (USG?S) OUTBREAK RESPONSE PLAN. BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA) IS SEEKIN | $17M → |
| Dec 12, 2024 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | IGF::OT::IGF | $50M → |
| Aug 30, 2024 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541714 | MEDICAL COUNTERMEASURES (MCM) THAT CAN BE DEPLOYED IN THE EVENT OF A FILOVIRUS OUTBREAK ARE A CRUCIAL COMPONENT TO THE UNITED STATES GOVERNMENT?S (USG?S) OUTBREAK RESPONSE PLAN. BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA) IS SEEKIN | $42M → |
| Jun 28, 2024 | Department of Health and Human ServicesASPR/ORM-SNS | 325414 | ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM) | $100M → |
| Jun 26, 2024 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | IGF::OT::IGF | $30M → |
| Nov 21, 2023 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | IGF::OT::IGF | $75M → |
| Jul 31, 2023 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541714 | MEDICAL COUNTERMEASURES (MCM) THAT CAN BE DEPLOYED IN THE EVENT OF A FILOVIRUS OUTBREAK ARE A CRUCIAL COMPONENT TO THE UNITED STATES GOVERNMENT?S (USG?S) OUTBREAK RESPONSE PLAN. BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA) IS SEEKIN | $60M → |
| Jun 16, 2023 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | IGF::OT::IGF | $75M → |
| May 19, 2023 | Department of Health and Human ServicesASPR/ORM-SNS | 325414 | ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM) | $120M → |
| Mar 30, 2023 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | IGF::OT::IGF | $4.5M → |
| Mar 13, 2023 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 541712 | IGF::OT::IGF DEVELOPMENT OF VACCINE FORMULATIONS EFFECTIVE AGAINST NIAID PRIORITY PATHOGENS | $476K → |
| Oct 27, 2022 | Department of DefenseARMY MED RES ACQ ACTIVITY | 541715 | CREATION OF AN FDA APPROVED ANALGESIC KETAMINE DRUG WITH AUTO INJECTOR DELIVERY SYSTEM. | $6.8M → |
| Aug 24, 2022 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | IGF::OT::IGF - ADVANCING STABILIZED ISOAMYL NITRITE FOR INTRANASAL TREATMENT OF CYANIDE EXPOSURE | $6.8M → |
| Jul 1, 2022 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | TAS::75 0140::TAS ADVANCED DEVELOPMENT OF RECOMBINANT PROTECTIVE ANTIGENT (RPA) ANTHRAX VACCINE CAN 1990087 | $8.0M → |
| May 19, 2022 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 541712 | IGF::OT::IGF DEVELOPMENT OF VACCINE FORMULATIONS EFFECTIVE AGAINST NIAID PRIORITY PATHOGENS | $69K → |
| Sep 30, 2021 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | IGF::OT::IGF | $399M → |
| Jul 5, 2021 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 325414 | ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM) | $182M → |
| Jun 10, 2021 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 541710 | BIOMEDICAL (BASIC) | $749K → |
| Jun 10, 2021 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 541711 | NEW AWARD UNDER BAA NIH-NIAID-DMID-08-20. THIS IS ONE OF FOUR AWARDS UNDER THIS BAA. | $1.4M → |
| Jun 8, 2021 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 541712 | BIOMEDICAL (ADVANCED) | $2.6M → |
Want to win work like Emergent Product Development Gaithersburg INC.?
Their contracts will eventually end — and when they do, the government has to award that work again. Mindy tells you up to a year early, so you can be ready to compete for it.